Blood Transfusions and Blood Components (Angelina L. Mirasol, MD) Flashcards
(38 cards)
Also known as the Blood Services Act of 1994
RA 7719
What does RA 7719 emphasize?
Voluntary and non-profit collection of blood
Blood donation as a humanitarian act
Provide safe, affordable and equitable distribution of blood
What must each blood unit be labelled with?
ABO and RhD group
Risks associated with allogenic red cell transfusion
Transfusion reactions
Disease transmission
Immunomodulation
Detection, data gathering and analysis of adverse events of blood transfusion
Hemovigilance
When should blood transfusion be performed?
When the required tests are done and the benefits outweigh the risks
T/F: If possible, transfuse blood components rather than whole blood.
True
When is informed consent for transfusion not needed?
Life-threatening emergencies
Allows single blood donation to provide treatment for several patients
Fractionation of blood
Blood component that transmits most of the infections present in whole blood
Plasma
Composition of whole blood
Hct 40% / 570 mL
Indications for the use of whole blood
Symptomatic anemia with large volume deficiet (except severe chronic anemia)
Loss of both RBC and plasma volume
Viability of Pakced Red Blood Cells (PRBCs)
35 days (stored in CPDA-1) to 42 days (stored in AS)
Composition of PRBC
Hct 55 - 70% / 330 mL
Indications for use of PRBC
Symptomatic anemia
Hgb < 7 g/dl or Hct <21%
Examples of red blood cell substitutes
Fluorocarbon-based synthetic oxygen carriers
Stroma free, cross-linked or polymerized human or nonhuman hemoglobin preparation
When are red blood cell substitutes useful?
Acute massive blood loss (trauma or major operation)
Patients declining transfusion for religious reasons
Contraindications to RBC transfusion
- Volume expansion when oxygen carrying capacity is adequate
- Prophylaxis w/o symptoms of anemia
- Enhance sense of well-being
- Promote wound healing
Indications for platelet transfusion therapy
Therapeutic
Prophylactic
Guidelines for platelet transfusion
P1 - Count <100,000
P5 - Massive transfusion with diffuse microvascular bleeding
P6 - Others
Appropriate dose for platelet transfusion therapy
1 unit/10 kg body weight (max 8 units)
Disorders where platelet transfusion is not useful
Drug induced thrombocytopenia Thrombotic thrombocytopenia purpura Hemolytic-uremic syndrome Idiopathic thrombocytopenia purpura Heparin induced thrombocytopenia Conditions where platelets are destroyed or not activated
Usual adult dose of random donor platelets
6 units
What increment is expected to be achieved following transfusion with random donor platelets?
30,000/uL (each unit expected to raise platelet count by 5,000/uL)